988
Views
11
CrossRef citations to date
0
Altmetric
Review

Depression, Anxiety, and Substance Use Disorders and Treatment Receipt Among Pregnant Women in the United States: A Systematic Review of Trend and Population-Based Studies

, PhD, RN & , DrPH, RN

References

  • Accortt, E. E., Cheadle, A. C., & Dunkel Schetter, C. 2015. Prenatal depression and adverse birth outcomes: An updated systematic review. Maternal and Child Health Journal, 19 (6), 1306–1337. doi:10.1007/s10995-014-1637-2
  • Accortt, E. E., & Wong, M. S. 2017. It is time for routine screening for perinatal mood and anxiety disorders in obstetrics and gynecology settings. Obstetrical & Gynecological Survey, 72 (9), 553–568. doi:10.1097/OGX.0000000000000477
  • Agency for Healthcare Research and Quality. 2016. Screening for Depression. Retrieved from http://www.ahrq.gov/professionals/prevention-chronic-care/healthier-pregnancy/preventive/depression.html
  • Alexander, K. 2017. A call for compassionate care. Journal of Addictions Nursing, 28 (4), 220–223. doi:10.1097/JAN.0000000000000198
  • American College of Obstetricians and Gynecologists (ACOG). 2015a. Committee opinion no. 633: Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. (2015). Obstetrics and Gynecology, 125 (6), 1529–1537. doi:10.1097/01.AOG.0000466371.86393.9b
  • American College of Obstetricians and Gynecologists (ACOG). 2015b. Screening for perinatal depression. Retrieved from https://www.acog.org/-/media/Committee-Opinions/Committee-on-Obstetric-
  • American Psychiatric Association (APA). 1994. Diagnostic and statistical manual of mental disorders: DSM IV (4th ed.). Washington, DC: American Psychiatric Association (APA).
  • Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., … Platt, R. 2008. Use of antidepressant medications during pregnancy: a multisite study. American Journal of Obstetrics and Gynecology, 198 (2), 194.e1–e191-194. e195. doi:10.1016/j.ajog.2007.07.036
  • Bennett, I. M., Marcus, S. C., Palmer, S. C., & Coyne, J. C. 2010. Pregnancy-related discontinuation of antidepressants and depression care visits among Medicaid recipients. Psychiatric Services, 61 (4), 386–391. doi:10.1176/ps.2010.61.4.386
  • Benningfield, M. M., Arria, A. M., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., … Martin, P. R. 2010. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. The American Journal on Addictions, 19 (5), 416–421. doi:10.1111/j.1521-0391.2010.00064.x
  • Bobo, W. V., Epstein, R. A., Hayes, R. M., Shelton, R. C., Hartert, T. V., Mitchel, E., …, Wu, P. 2014. The effect of regulatory advisories on maternal antidepressant prescribing, 1995–2007: An interrupted time series study of 228,876 pregnancies. Archives of Women's Mental Health, 17 (1), 17–26. doi:10.1007/s00737-013-0383-6
  • Byatt, N., Levin, L. L., Ziedonis, D., Simas, T. A. M., & Allison, J. 2015. Enhancing participation in depression care in outpatient perinatal care settings: a systematic review. Obstetrics & Gynecology, 126 (5), 1048–1058. doi:10.1097/AOG.0000000000001067
  • Byatt, N., Simas, T. A. M., Lundquist, R. S., Johnson, J. V., & Ziedonis, D. M. 2012. Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. Journal of Psychosomatic Obstetrics & Gynecology, 33 (4), 143–161. doi:10.3109/0167482X.2012.728649
  • Byatt, N., Xiao, R. S., Dinh, K. H., & Waring, M. E. 2016. Mental health care use in relation to depressive symptoms among pregnant women in the USA. Archives of Women's Mental Health, 19 (1), 187–191. doi:10.1007/s00737-015-0524-1
  • Center for Substance Abuse Treatment (CSAT). 2009. Substance abuse treatment: Addressing the specific needs of women. Retrieved from http://store.samhsa.gov/shin/content//SMA15-4426/SMA15-4426.pdf
  • Centers for Disease Control and Prevention. 2013. Vital signs: Overdoses of prescription opioid pain relievers and other drugs among women–United States, 1999-2010. MMWR. Morbidity and Mortality Weekly Report, 62 (26), 537.
  • Chang, J. J., Tabet, M., Elder, K., Kiel, D. W., & Flick, L. H. 2016. Racial/ethnic differences in the correlates of mental health services use among pregnant women with depressive symptoms. Maternal and Child Health Journal, 20 (9), 1911–1922. doi:10.1007/s10995-016-2005-1
  • Coleman-Cowger, V. H. 2012. Mental health treatment need among pregnant and postpartum women/girls entering substance abuse treatment. Psychology of Addictive Behaviors, 26 (2), 345–350. doi:10.1037/a0025355
  • Connelly, C. D., Hazen, A. L., Baker-Ericzen, M. J., Landsverk, J., & Horwitz, S. M. 2013. Is screening for depression in the perinatal period enough? The co-occurrence of depression, substance abuse, and intimate partner violence in culturally diverse pregnant women. Journal of Women’s Health (Larchmt), 22 (10), 844–852. doi:10.1089/jwh.2012.4121
  • Cook, C. A., Flick, L. H., Homan, S. M., Campbell, C., McSweeney, M., & Gallagher, M. E. 2010. Psychiatric disorders and treatment in low-income pregnant women. Journal of Women's Health (Larchmt), 19 (7), 1251–1262. doi:10.1089/jwh.2009.1854
  • Csaszar, E., Melichercikova, K., & Dubovicky, M. 2014. Neuroendocrine and behavioral consequences of untreated and treated depression in pregnancy and lactation. Neuro Endocrinology Letters, 35 (2), 169–174.
  • El Marroun, H., White, T., Verhulst, F. C., & Tiemeier, H. 2014. Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: A systematic review. European Child & Adolescent Psychiatry, 23 (10), 973–992. doi:10.1007/s00787-014-0558-3
  • Farr, S. L., Ko, J. Y., Burley, K., & Gupta, S. 2016. Provider communication on perinatal depression: A population-based study. Archives of Women's Mental Health, 19 (1), 35–40. doi:10.1007/s00737-014-0493-9
  • Geier, M. L., Hills, N., Gonzales, M., Tum, K., & Finley, P. R. 2015. Detection and treatment rates for perinatal depression in a state Medicaid population. CNS Spectrums, 20 (1), 11–19. doi:10.1017/S1092852914000510
  • Genovez, M., Vanderkruik, R., Lemon, E., & Dimidjian, S. 2018. Psychotherapeutic treatments for depression during pregnancy. Clinical Obstetrics and Gynecology, 61 (3), 562–572. doi:10.1097/GRF.0000000000000388
  • Glasheen, C., Colpe, L., Hoffman, V., & Warren, L. K. 2015. Prevalence of serious psychological distress and mental health treatment in a national sample of pregnant and postpartum women. Maternal and Child Health Journal, 19 (1), 204–216. doi:10.1007/s10995-014-1511-2
  • Goodman, J. H. 2009. Women’s attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth, 36 (1), 60–69. doi:10.1111/j.1523-536X.2008.00296.x
  • Goodman, J. H. 2019. Perinatal depression and infant mental health. Archives of Psychiatric Nursing, 33, 217–224. doi:10.1016/j.apnu.2019.01.010
  • Goodman, J. H., Chenausky, K. L., & Freeman, M. P. 2014. Anxiety disorders during pregnancy: A systematic review. The Journal of Clinical Psychiatry, 75 (10), e1153–1184. doi:10.4088/JCP.14r09035
  • Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Tomlinson, G., Dennis, C.-L., Koren, G., …, Ross, L. E. 2013. The impact of maternal depression during pregnancy on perinatal outcomes: A systematic review and meta-analysis. The Journal of Clinical Psychiatry, 74 (4), e321–341. doi:10.4088/JCP.12r07968
  • Hand, D. J., Short, V. L., & Abatemarco, D. J. 2017. Substance use, treatment, and demographic characteristics of pregnant women entering treatment for opioid use disorder differ by United States census region. Journal of Substance Abuse Treatment, 76, 58–63. doi:10.1016/j.jsat.2017.01.011
  • Hanley, G. E., & Mintzes, B. 2014. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy and Childbirth, 14, 242. doi:10.1186/1471-2393-14-242
  • Irner, T. B., Teasdale, T. W., Nielsen, T., Vedal, S., & Olofsson, M. 2012. Substance use during pregnancy and postnatal outcomes. Journal of Addictive Diseases, 31 (1), 19–28. doi:10.1080/10550887.2011.642765
  • Jaques, S. C., Kingsbury, A., Henshcke, P., Chomchai, C., Clews, S., Falconer, J., … Oei, J. L. 2014. Cannabis, the pregnant woman and her child: Weeding out the myths. Journal of Perinatology, 34 (6), 417–424. doi:10.1038/jp.2013.180
  • Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., … Zaslavsky, A. M. 2003. Screening for serious mental illness in the general population. Archives of General Psychiatry, 60 (2), 184–189. doi:10.1001/archpsyc.60.2.184
  • Kingston, D., Tough, S., & Whitfield, H. 2012. Prenatal and postpartum maternal psychological distress and infant development: a systematic review. Child Psychiatry & Human Development, 43 (5), 683–714. doi:10.1007/s10578-012-0291-4
  • Ko, J. Y., Farr, S. L., Dietz, P. M., & Robbins, C. L. 2012. Depression and treatment among US pregnant and nonpregnant women of reproductive age, 2005–2009. Journal of Women's Health, 21 (8), 830–836. doi:10.1089/jwh.2011.3466
  • Kotelchuck, M., Cheng, E. R., Belanoff, C., Cabral, H. J., Babakhanlou-Chase, H., Derrington, T. M., … Bernstein, J. 2017. The prevalence and impact of substance use disorder and treatment on maternal obstetric experiences and birth outcomes among singleton deliveries in Massachusetts. Maternal and Child Health Journal, 21 (4), 893–902. doi:10.1007/s10995-016-2190-y
  • Kozhimannil, K. B., Graves, A. J., Levy, R., & Patrick, S. W. 2017. Nonmedical use of prescription opioids among pregnant US women. Women's Health Issues, 27 (3), 308–315. doi:10.1016/j.whi.2017.03.001
  • Kuo, C., Schonbrun, Y. C., Zlotnick, C., Bates, N., Todorova, R., Kao, J. C., & Johnson, J. 2013. A qualitative study of treatment needs among pregnant and postpartum women with substance use and depression. Substance Use & Misuse, 48 (14), 1498–1508. doi:10.3109/10826084.2013.800116
  • Lambert, B., & Bauer, C. R. 2012. Developmental and behavioral consequences of prenatal cocaine exposure: A review. Journal of Perinatology, 32 (11), 819–828. doi:10.1038/jp.2012.90
  • Lancaster, C. A., Gold, K. J., Flynn, H. A., Yoo, H., Marcus, S. M., & Davis, M. M. 2010. Risk factors for depressive symptoms during pregnancy: A systematic review. American Journal of Obstetrics and Gynecology, 202 (1), 5–14. doi:10.1016/j.ajog.2009.09.007
  • Le Strat, Y., Dubertret, C., & Le Foll, B. 2011. Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States. Journal of Affective Disorders, 135 (1-3), 128–138. doi:10.1016/j.jad.2011.07.004
  • Lehikoinen, A., Orden, M. R., Heinonen, S., & Voutilainen, R. 2016. Maternal drug or alcohol abuse is associated with decreased head size from mid-pregnancy to childhood. Acta Paediatrica, 105 (7), 817–822. doi:10.1111/apa.13416
  • Liu, C. H., & Tronick, E. 2012. Do patient characteristics, prenatal care setting, and method of payment matter when it comes to provider-patient conversations on perinatal mood?. Maternal and Child Health Journal, 16 (5), 1102–1112. doi:10.1007/s10995-011-0835-4
  • Maeda, A., Bateman, B. T., Clancy, C. R., Creanga, A. A., & Leffert, L. R. 2014. Opioid abuse and dependence during pregnancy temporal trends and obstetrical outcomes. Anesthesiology, 121 (6), 1158–1165. doi:10.1097/ALN.0000000000000472
  • Marais, S., Jordaan, E., Viljoen, D., Olivier, L., de Waal, J., & Poole, C. 2011. The effect of brief interventions on the drinking behaviour of pregnant women in a high‐risk rural south african community: A cluster randomised trial. Early Child Development and Care, 181 (4), 463–474. doi:10.1080/03004430903450392
  • Marc, I., Toureche, N., Ernst, E., Hodnett, E. D., Blanchet, C., Dodin, S., & Njoya, M. M. 2011. Mind‐body interventions during pregnancy for preventing or treating women's anxiety. Cochrane Database of Systematic Reviews, 7 (7),CD007559.
  • Marcellus, L. 2014. Supporting women with substance use issues: Trauma informed care as a foundation for practice in the NICU. Neonatal Network, 33 (60), 307–314. doi:10.1891/0730-0832.33.6.307
  • Marcellus, L. 2018. Social ecological examination of factors that influence the treatment of newborns with neonatal abstinence syndrome. Journal of Obstetric, Gynecologic & Neonatal Nursing, 47 (4), 509–519. doi:10.1016/j.jogn.2018.04.135
  • Martin, C. E., Longinaker, N., Mark, K., Chisolm, M. S., & Terplan, M. 2015. Recent trends in treatment admissions for marijuana use during pregnancy. Journal of Addiction Medicine, 9 (2), 99–104. doi:10.1097/ADM.0000000000000095
  • Martin, C. E., Longinaker, N., & Terplan, M. 2015. Recent trends in treatment admissions for prescription opioid abuse during pregnancy. Journal of Substance Abuse Treatment, 48 (1), 37–42. doi:10.1016/j.jsat.2014.07.007
  • May, P. A., Marais, A.-S., Gossage, J. P., Barnard, R., Joubert, B., Cloete, M., … Blankenship, J. 2013. Case management reduces drinking during pregnancy among high risk women. The International Journal of Alcohol and Drug Research, 2 (3), 61–70. doi:10.7895/ijadr.v2i3.79
  • McCabe, J. E., & Arndt, S. 2012. Demographic and substance abuse trends among pregnant and non-pregnant women: Eleven years of treatment admission data. Maternal and Child Health Journal, 16 (8), 1696–1702. doi:10.1007/s10995-011-0872-z
  • Mental Health Parity and Addiction Equity Act (MHPAEA). 2008. Pub. L. No. 110-343, 122 Stat. 3765, H.R. 1424, 110th Cong. Retrieved from https://www.cms.gov/CCIIO/Programs-and-Initiatives/Other-Insurance-Protections/mhpaea_factsheet.html#Key changes made by MHPAEA
  • Metz, T. D., & Stickrath, E. H. 2015. Marijuana use in pregnancy and lactation: A review of the evidence. American Journal of Obstetrics and Gynecology, 213 (6), 761–778. doi:10.1016/j.ajog.2015.05.025
  • Meunier, M. R., Bennett, I. M., & Coco, A. S. 2013. Use of antidepressant medication in the United States during pregnancy, 2002–2010. Psychiatric Services, 64 (11), 1157–1160. doi:10.1176/appi.ps.201200455
  • Meyer, M. C., Johnston, A. M., Crocker, A. M., & Heil, S. H. 2015. Methadone and buprenorphine for opioid dependence during pregnancy: A retrospective cohort study. Journal of Addiction Medicine, 9 (2), 81–86. doi:10.1097/ADM.0000000000000092
  • Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Group, P. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6 (7), e1000097. doi:10.1371/journal.pmed.1000097
  • Mota, N., Cox, B. J., Enns, M. W., Calhoun, L., & Sareen, J. 2008. The relationship between mental disorders, quality of life, and pregnancy: findings from a nationally representative sample. Journal of Affective Disorders, 109 (3), 300–304. doi:10.1016/j.jad.2007.12.002
  • Narkowicz, S., Płotka, J., Polkowska, Ż., Biziuk, M., & Namieśnik, J. 2013. Prenatal exposure to substance of abuse: A worldwide problem. Environment International, 54, 141–163. doi:10.1016/j.envint.2013.01.011
  • O’connor, E., Rossom, R. C., Henninger, M., Groom, H. C., & Burda, B. U. 2016. Primary care screening for and treatment of depression in pregnant and postpartum women: Evidence report and systematic review for the US Preventive Services Task Force. JAMA, 315 (4), 388–406. doi:10.1001/jama.2015.18948
  • Ondersma, S. J., Simpson, S. M., Brestan, E. V., & Ward, M. 2000. Prenatal drug exposure and social policy: The search for an appropriate response. Child Maltreatment, 5 (2), 93–108. doi:10.1177/1077559500005002002
  • Pan, I.-J., & Yi, H-y. 2013. Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999–2008. Maternal and Child Health Journal, 17 (4), 667–676. doi:10.1007/s10995-012-1046-3
  • Patient Protection and Affordable Care Act (PPACA). 2010, 42 U.S.C. § 1800 Retrieved from https://www.gpo.gov/fdsys/pkg/PLAW-111publ148/html/PLAW-111publ148.htm
  • Patrick, S. W., Davis, M. M., Lehmann, C. U., & Cooper, W. O. 2015. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of Perinatology, 35 (8), 650–655. doi:10.1038/jp.2015.36
  • Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. 2012. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. Journal of the American Medical Association, 307 (18), 1934–1940. doi:10.1001/jama.2012.3951
  • Price, S. K., Corder-Mabe, J., & Austin, K. 2012. Perinatal depression screening and intervention: Enhancing health provider involvement. Journal of Women's Health, 21 (4), 447–455. doi:10.1089/jwh.2011.3172
  • Roberson, E. K., Hurwitz, E. L., Li, D., Cooney, R. V., Katz, A. R., & Collier, A. C. 2016. Depression, anxiety, and pharmacotherapy around the time of pregnancy in Hawaii. International Journal of Behavioral Medicine, 23 (4), 515–526. doi:10.1007/s12529-015-9493-z
  • Rossen, L., Hutchinson, D., Wilson, J., Burns, L., Olsson, C. A., Allsop, S., … Mattick, R. P. 2016. Predictors of postnatal mother-infant bonding: The role of antenatal bonding, maternal substance use and mental health. Archives of Women's Mental Health, 19 (4), 609–622. doi:10.1007/s00737-016-0602-z
  • Schottenfeld, R. S., Moore, B., & Pantalon, M. V. 2011. Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children. Drug and Alcohol Dependence, 118 (1), 48–55. doi:10.1016/j.drugalcdep.2011.02.019
  • Snowden, L. R. 2012. Health and mental health policies' role in better understanding and closing African American-White American disparities in treatment access and quality of care. American Psychologist, 67 (7), 524–531. doi:10.1037/a0030054
  • Substance Abuse and Mental Health Services Administration (AMHSA). 2014b. SAMHSA’s concept of trauma and guidance for a trauma-informed approach. Retrieved from http://store.samhsa.gov/shin/content/SMA14-4884/SMA14-4884.pdf
  • Substance Abuse and Mental Health Services Administration (SAMHSA). 2014a. Results from the 2013 National Survey on Drug Use and Health: Summary of national findings. Retrieved from http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf
  • Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. 2017. Treatment Episode Data Set -Admissions (TEDS-A) Series. Retrieved from https://www.icpsr.umich.edu/icpsrweb/ICPSR/series/56
  • Terplan, M., McNamara, E. J., & Chisolm, M. S. 2012. Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt. Journal of Addictive Diseases, 31 (4), 342–349. doi:10.1080/10550887.2012.735566
  • Thombs, B. D., Arthurs, E., Coronado-Montoya, S., Roseman, M., Delisle, V. C., Leavens, A., … Zelkowitz, P. 2014. Depression screening and patient outcomes in pregnancy or postpartum: A systematic review. Journal of Psychosomatic Research, 76 (6), 433–446. doi:10.1016/j.jpsychores.2014.01.006
  • Tolia, V. N., Patrick, S. W., Bennett, M. M., Murthy, K., Sousa, J., Smith, P. B., … Spitzer, A. R. 2015. Increasing incidence of the neonatal abstinence syndrome in US neonatal ICUs. New England Journal of Medicine, 372 (22), 2118–2126. doi:10.1056/NEJMsa1500439
  • United States Department of Health and Human Services (USDHHS). 2009. Actions steps for improving women’s mental health. Retrieved from https://store.samhsa.gov/shin/content/OWH09-PROFESSIONAL/OWH09-PROFESSIONAL.pdf
  • United States Department of Justice, National Drug Intelligence center. 2011. National drug threat assessment. Retrieved from https://www.justice.gov/archive/ndic/pubs44/44849/44849p.pdf
  • van der Zee-van den Berg, A. I., Boere-Boonekamp, M. M., IJzerman, M. J., Haasnoot-Smallegange, R. M. E., & Reijneveld, S. A. 2017. Screening for postpartum depression in well-baby care settings: A systematic review. Maternal and Child Health Journal, 21 (1), 9–20. doi:10.1007/s10995-016-2088-8
  • Vesga-Lopez, O., Blanco, C., Keyes, K., Olfson, M., Grant, B. F., & Hasin, D. S. 2008. Psychiatric disorders in pregnant and postpartum women in the United States. Archives of General Psychiatry, 65 (7), 805–815. doi:10.1001/archpsyc.65.7.805
  • Wu, J., & Davis-Ajami, M. L. 2014. Antidepressant treatment persistence in low-income, insured pregnant women. Journal of Managed Care Pharmacy, 20 (6), 631–637. doi:10.18553/jmcp.2014.20.6.631
  • Yamamoto, A., McCormick, M. C., & Burris, H. H. 2015. Disparities in antidepressant use in pregnancy. Journal of Perinatology, 35 (4), 246–251. doi:10.1038/jp.2014.197
  • Yonkers, K. A., Forray, A., Howell, H. B., Gotman, N., Kershaw, T., Rounsaville, B. J., & Carroll, K. M. 2012. Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: A randomized trial for treatment of hazardous substance use in pregnancy and after delivery. General Hospital Psychiatry, 34 (5), 439–449. doi:10.1016/j.genhosppsych.2012.06.002
  • Yonkers, K. A., Wisner, K. L., Stewart, D. E., Oberlander, T. F., Dell, D. L., Stotland, N., … Lockwood, C. 2009. The management of depression during pregnancy: A report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. General Hospital Psychiatry, 31 (5), 403–413. doi:10.1016/j.genhosppsych.2009.04.003

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.